Josamycin

This classification denotes a macrolide antibiotic with the molecular formula C42H69NO15, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier HV13HFS217, chemically known as stereoisomer of 7-(formylmethyl)-4,10-dihydroxy-5-methoxy-9,16-dimethyl-2-oxooxacyclohexadeca-11,13-dien-6-yl 3,6-dideoxy-4-o-(2,6-dideoxy-3-c-methyl-alpha-l-ribo-hexopyranosyl)-3-(dimethylamino)-beta-d-glucopyranoside 4-acetate 4-isovalerate but generally known as josamycin, which bears US NIH Compound Identifier 5282165. European Medicines Agency schedules Josamycin in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB12091MIG. The term JOSAMYCIN is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 24, No. 11 1970, List 10). World Health Organization schedules josamycin in its Anatomical Therapeutic Chemical (ATC) Classification. JOSAMYCIN is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule josamycin under HS 29419000 and SITC 54139. As of Q4 2014, JOSAMYCIN remains the US FDA Preferred Term for this commodity. Josamycin bears US NLM identifiers UMLS ID C0022419 and NCI Concept Code C83851. SMILES: O(C1C(N(C)C)C(O)C(OC1C)OC1C(CC(C(O)C=CC=CCC(OC(=O)CC(OC(=O)C)C1OC)C)C)CC=O)C1OC(C(OC(=O)CC(C)C)C(O)(C1)C)C.